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The let-60 gene of Caenorhabditis elegans controls the choice between vulval and hypodermal differentiation 
in response to an inductive signal from the gonad, let-60 encodes a ras protein that acts downstream of the 
let-23 receptor tyrosine kinase in a signal transduction pathway. Dominant-negative mutations of let-60 
[let-60(dn)] cause a reduction of the gene activity in let-60(dn)/+ heterozygotes and a vulva-less mutant 
phenotype. We have found that nine let-60(dn) mutations cause replacements of conserved residues. Four are 
in two novel positions; others are in positions known previously to cause dominant-negative mutations in 
mammalian cells. The locations of these lesions suggest hat they disrupt the ability of the ras protein to bind 
guanine nucleotides. Four let-60(dn) mutant genes were introduced into wild-type animals in the form of 
extrachromosomal rrays and were found to generate three dominant phenotypes---lethality, vulva-less, or 
multivulva--depending on gene dose and alleles. The dominant lethality caused by high-dose transgenic 
let-60(dn) genes suggests a toxic effect of these mutant genes in early development. The dominant-negative 
effects of these mutations in heterozygotes are likely to be caused by competition between let-60(dn) and 
let-60(+) protein for a positive regulator. All let-60(dn) mutations interfere with let-60(+) activity, but some 
alleles have partial constitutive activity, suggesting that the ability to interact with the activator is separable 
from the ability to exert a physiological effect (stimulation of vulval differentiation). These dn mutations 
might be useful for interfering with ras-mediated signal transduction pathways in other multicellular 
organisms. 
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Prior to vulval differentiation i Caenorhabditis elegans 
hermaphrodites, each of six vulval precursor cells (VPCs; 
posterior daughter cells of six ectodermal P cells, P3.p- 
P8.p) has the potential to generate ither vulval cells or 
hypodermal cells. According to the current model, dur- 
ing vulval induction, three of the six precursor cells are 
triggered to generate vulval cells by an inductive signal 
from the anchor cell in the gonad (for review, see Horvitz 
and Sternberg 1991). In the absence of the inductive sig- 
nal, the vulval cell fates for these precursor cells are re- 
pressed by an inhibitory signal from the large syncytial 
hypodermis (hyp7) mediated by the lin-15 gene (Ferguson 
et al. 1987; Herman and Hedgecock 1990). 
Genetic analysis indicated that let-60 activity controls 
the choice of differentiation between the vulval and hy- 
podermal cell fates in response to the intercellular sig- 
nals (Fig. 1; Beitel et al. 1990; Han et al. 1990). Specifi- 
cally, low let-60 activity results in fewer than three of 
1Present address: Department of Molecular, Cellular, and Developmen- 
tal Biology, University of Colorado at Boulder, Boulder, Colorado 80309- 
0347 USA. 
the six VPCs differentiating into vulval tissue (the vulva- 
less or Vul phenotype), while high let-60 activity results 
in extra VPCs differentiating into vulval tissue (the mul- 
tivulva or Muv phenotype), let-60 encodes a ras protein 
with 83% of its first 164 amino acids (of a total 184) 
identical to those in the human N-ras protein (Han and 
Steinberg 1990). Genetic epistasis experiments suggest 
that let-60 ras acts downstream of let-23, a member of 
the epidermal growth factor (EGF) receptor family of ty- 
rosine kinases (Aroian et al. 1990), in a signal transduc- 
tion pathway (Han et al. 1990; Hart and Sternberg 1990). 
Gain-of-function mutations in let-60 ras [let-60(gf)] 
produce constitutively high let-60 activity and a Muv 
phenotype (Fergnson and Horvitz 1985; Beitel et al. 
1990; Han et al. 1990; G. Jongeward and P. Sternberg, 
unpubl.). The five independently isolated let-60(gf) mu- 
tations have the same DNA lesion at codon 13 (Beitel et 
al. 1990); such a change in mammalian ras leads to a 
decrease in the GTPase activity of the ras protein (for 
review, see Barbacid 1987). The gain-of-function (Muv) 
mutant phenotype can also be caused by extra copies of 
extrachromosomal wild-type let-60 ras gene (Han and 
2188 GENES & DEVELOPMENT 5:2188-2198 9 1991 by Cold Spring Harbor Laboratory ISSN 0890-9369/91 $3.00 
 Cold Spring Harbor Laboratory Press on May 19, 2017 - Published by genesdev.cshlp.orgDownloaded from 
inductive signal vulval cell fates 
~"- - .~  let-23 let-60 "~"~"~ 
receptor ~ ras 
tyrosine kinase 
hypodermal 
inhibitory signal cell fate 
(;in-15) 
Figure 1. The role of let-60 ras in the control of vulval devel- 
opment. The level of let-60 ras activity controls the decision 
between vulval and hypodermal fates for each of the six vulval 
precursor cells in response toupstream intercellular signals (Be- 
itel et al. 1990; Han et al. 1990). Specifically, low let-60 activity 
results in hypodermal fate specification, whereas high let-60 
activity leads to vulval fate specifications, let-60 activity, nor- 
mally regulated by the upstream signals, is rendered constitu- 
tively low by let-60 If or dn mutations, or constitutively high by 
let-60 gf mutations, let-60 ras has been proposed to act down- 
stream of let-23 (Han and Sternberg 1990; Han et al. 1990), 
which encodes a receptor tyrosine kinase {Aroian et al. 1990). 
Stemberg 1990), suggesting that endogenous gene ex- 
pression might be controlled quantitatively. 
The opposite mutant  phenotype, Vul, is caused by 
loss-of-function (If) and dominant-negative (dn)muta- 
tions oflet-6Oras (Beitel et al. 1990; Han et al. 1990). The 
nine let-60(dn) mutations cause a dominant Vul-less 
phenotype in hermaphrodites and a dominant defect in 
male tail morphology and mating ability. Eight of these 
mutations are recessive lethal at an early larval stage, 
consistent with the conclusion that let-60 is also essen- 
tial for larval growth based on analysis of let-60(lf) mu- 
tations. The dominant-negative effect in let-60(dn)/+ 
heterozygotes is caused presumably by an interference of 
let-60( + ) protein function by the let-60(dn) protein. 
Previously, a number of mutations in guanine nucle- 
otide-binding regions of ras proteins have been con- 
structed or selected in vitro and found to have dominant- 
negative ffects in mammal ian or in yeast cells (Sigal et 
C. elegans dominant-negative ras mutations 
al. 1986; Feig and Cooper 1988; Powers et al. 1989). How- 
ever, it is of interest to compare the in vivo-selected 
dominant-negative mutations of the C. elegans let-60 ras 
gene with those mutations tudied previously. 
In this study we determined the molecular lesions 
caused by the nine let-60(dn) mutations. We also deter- 
mined the DNA alteration for two let-60(dn) intragenic 
revertants and found that one is an excellent candidate 
for a null mutation. Our results suggest hat the dn mu- 
tations likely disrupt the ability of let-60 ras protein to 
bind guanine nucleotides and, therefore, prevent its ac- 
tivation. To understand the mechanism of the domi- 
nant-negative effect caused by these let-60(dn) alleles in 
heterozygotes, we further analyzed transgenic animals 
carrying exogenous let-60(dn) genes and examined the 
extent of vulval differentiation for two representative 
let-60(dn) mutations with various ratios of mutant  to 
wild-type genes. We discuss the implications of these 
results as well as a model for competition between the 
]et-60(dn) and let-60(+) proteins. 
Resul ts  
All dominant-negative mutations of let-60 ras l ikely 
cause defective guanine nucleotide binding 
We have determined the sequence alterations of all nine 
let-60(dn) mutations, after obtaining let-60 DNA frag- 
ments from mutants by polymerase chain reaction (PCR) 
amplification (Table 1). For example, let-60(sylO1) re- 
sults in a substitution of arginine for glycine at position 
10; we refer to this as let-60(Arg-lO). Figure 2 shows the 
three-dimensional crystal structure of the GTP-bound 
form of a truncated mammal ian p21 ras protein (Pai et al. 
1989, 1990; Tong et al. 1991). Because there are no gaps 
in the alignment between let-60 ras and mammal ian  ras 
proteins until after residue 179, the positions of let- 
60(dn) mutant residues likely correspond to those in 
Table 1. DNA and protein lesion of let-60(dn) and revertant mutations 
nucleotide amino acid 
Class Allele Codon wild type mutant wild type mutant 
Dominant-negative (tin)" sy99 10 GGA AGA Gly Arg 
syl O1 10 GGA AGA Gly Arg 
n2301 15 GGT AGT Gly Ser 
n1531 15 GGT GAT Gly Asp 
sy94 16 AAA AAT Lys Ash 
sy92 89 TCT TTT Set Phe 
sy95 89 TCT TTT Ser Phe 
sylO0 89 TCT TTT Set Phe 
sy93 119 GAT AAT Asp Asn 
Revertant of dn b sy163 110 CCT TCT Pro Set 
sy127 123 CGA TGA Arg Stop 
~Genetic haracterization f these dn mutations was described by Han et al. [1990) for alleles named sy and by Beitel et al. [1990) for 
alleles named n. Pbe-89 dn is equivalent to the intragenic revertant (n1981) of an activated let-60 mutant protein (n1046 or Glu-13 gf}. 
Glu-13 Pbe-89 protein does not act as an activated ras protein but has some dominant-negative activity (Beitel et al. 1990}. 
bThese two alleles were isolated as intragenic revertants of let-60(syl01 dn) (Han et al. 1990) and appear to eliminate function of let-60. 
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Figure 2. Three-dimensional structure of mam- 
malian p21ras. The ribbon diagram of the s t ruc -  
tu re  of the GTP-bound form of a truncated p21ras 
{residues 1-166; Pai et al. 1989) is adapted from 
Bourne et al. {1991) and depicts the positions of 
amino acid residues that were altered bylet-60(dn) 
mutations. 
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mammalian p21 ras. All of the Iet-60(dn) mutations alter 
amino acids that are invariant throughout evolution 
{Barbacid 1987; Han and Sternberg 1990)and appear to be 
in the region required for guanine nucleotide binding. 
Residues 10-17 form a loop in which main-chain amide 
hydrogens of several amino acids, plus the amino group 
of Lys-16, form hydrogen bonds with the ~- and B-phos- 
phates of GTP or GDP {Pai et al. 1990; Tong et al. 1991). 
Thus, Arg-10, Ser-15, Asp-15, and Asn-16 might disrupt 
the interaction of this loop with guanine nucleotides. 
Asp-119 is also required for GTP/GDP binding, as its 
carboxyl oxygens form hydrogen bonds with the guanine 
ring. Asn-119 is likely to disrupt these bonds. Ser-89 is 
not in direct contact with the guanine nucleotide, but its 
proximity to the binding site suggests that it might be 
important for stable binding. Phe-89 might disrupt such 
a role. Mutations in residues 16 and 119 of the mamma- 
lian ras protein cause a drastic (-100-fold} decrease in 
GTP/GDP-binding ability of the ras protein (Der et al. 
1986; Sigal et al. 1986). We conclude that all of the dn 
mutations are likely to cause defective guanine nucle- 
otide binding. 
An intragenJc let-60(dn) revertant causes a premature 
termination codon and a null phenotype 
Previously, we have isolated two intragenic revertants of
let-60(sylO1 dn) (named sy127 and sy163; Han et al. 
1990). let-60(syl0I sy127) or let-60(syl01 syi63) double 
mutants are recessive lethal but have no dominant phe- 
notypes: The let-60(dn, revertant)/+ heterozygotes have 
wild-type vulvae and normal male mating. The sequence 
changes of these two let-60(cln) intragenic revertants 
have been determined (Table 1). sy163 converts residue 
110 from the absolutely conserved proline to serine (Ser- 
110) while sy127 produces presumably a carboxy-termi- 
nal-truncated protein by introducing a stop codon (TGA) 
at residue 123 (Stop-123}. The sequence deleted in this 
truncated protein contains many conserved amino acids, 
including a region required for guanine nucleotide bind-. 
ing (Boume et al. 1991}, as well as the sites required for 
post-translational modifications and membrane attach- 
ment (Barbacid 1987; Gibbs 1991}. Therefore, Stop-123 is 
most likely a null mutation, let-60(Arg-10 Stop-123) ho- 
mozygotes hatch but die during the early part of the first 
larval (L1) stage. Specifically, we observed eight animals 
under Nomarski optics and found that the gonad of an 
arrested animal consists only of the four primordial 
cells; the M mesoblast divided once at most, the P ecto- 
blasts had not migrated to the ventral cord; and Ll-spe- 
cific alae are present in all arrested animals {Sulston and 
Horvitz 1977; Kimble and Hirsh 1979). On the basis of 
the phenotype under the dissecting microscope, Stop- 
123 also produces the most severe recessive lethal phe- 
notype among all of the loss-of-function mutations of 
let-60 ras; they have the smallest size on plates, and 
there are no "escapers" that survive to later stages, as is 
the case with other mutations (Clark et al. 1988; Beitel 
et al. 1990; Han et al. 1990). Therefore, animals with no 
zygotic Iet-60 function arrest at the young L 1 stage. It is 
possible that  maternal function of let-60 ras is required 
for animals to complete mbryogenesis. 
let-60{dn) transgenic animals exhibit mutant 
phenotypes 
To analyze further the nature of these dominant-nega- 
tive mutations, we reintroduced four different let-60(dn) 
genes into wild-type, animals along with a dominant 
marker, resulting in the production of extrachromo- 
somal DNA arrays {Table 2). The extrachromosomal ar-
rays in transgenic animals are typically >1000 kb long. 
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Table 2. Dominant-negative andgf phenotypes generated by extrachromosomal let-60(dn) DNA 
Number of 
transformants b 
Number of Phenotype c 
DNA" animals stable Number of 
Allele (~g/ml) injected F 1 lines % Vul % Muv n Ex genes a
Arg-10 10 10 0 0 
Asn-16 10 10 6 0 
Phe-89 10 10 -50 7 80 0 92 140 - 90 
Asn-ll9 10 10 -100 0 
Arg-10 1 17 >400 >7 85 0 93 6 + 1 
Ash-16 1 10 >550 >10 63 19 178 7 -+ 3 
Asn-ll9 1 13 >580 >28 60 20 115 5 -+ 1 
aOnly concentrations of injected let-60 DNA are indicated. (The concentrations of marker and carrier DNA are described in Materials 
and methods.) 
b(Fl) F 1 progeny carrying injected DNA; (stable lines) germ-line transformants. The extrachromosomal DNA is maintained semi-stably 
in germ-line transgenic animals (Mello et al. 1991). A dominant lethal effect is indicated by lack of stable transformants in some 
injection experiments. Transformants can be routinely obtained by just injecting marker and carrier DNA. Previously, we have also 
shown that injection of a 5'- or 3'-truncated let-60 gene does not cause any dominant effect. The dominant lethal phenotype is
therefore unlikely to be caused by titration of transcription factors by multiple copies of its DNA-binding sites {Han and Steinberg 
1990.) 
cPhenotypes determined under a dissecting microscope for a representative transgenic line for each experiment. (% Vul) Percent 
vulvaless; (% Muv)percent multivulval; (n) number of animals counted. 
aApproximate copy number (-+ 1 S.D.) of extrachromosomal let-60 genes in the transgenic lines estimated by PCR. 
The structure of the arrays and the gene copy numbers in 
individual transforming lines remain relatively stable 
through numerous generations of growth (Mello et al. 
1991). The ratio of DNAs in such extrachromosomal ar-
rays is similar to the ratio of DNAs in the solution in- 
jected, so that the approximate number of copies of a test 
gene relative to marker and carrier DNA can be con- 
trolled (Mello et al. 1991). 
When each of three let-60(dn) mutant genes (Arg-lO, 
Asn-16, and Asn-ll9) were injected into wild-type ani- 
mals at 1 ~g/ml ( -70 ~g/ml of total DNA; see Materials 
and methods), viable transformants were obtained and 
the expected Vul phenotype was observed. However, if 
the concentrations were increased to 10 ~g/ml, we were 
unable to obtain germ-line transformants from injection 
of any of the three mutant genes, indicating a dominant- 
lethal effect. In contrast, injection of a truncated let-60 
gene at 50 ~g/ml does not cause lethality or any domi- 
nant phenotype (Han and Sternberg 1990). Therefore, it 
is possible that the dn mutations also affect dominantly 
ras-mediated pathways during early larval growth. The 
fact that a low dose of let-60(dn) causes a Vul, but not a 
lethal, phenotype suggests that let-60 ras function dur- 
ing vulval development is more sensitive to the change 
in its activity level than its essential functions during 
early development. At the same concentration (10 ~g/ 
ml), injection of let-60(Phe-89 dn) produces viable trans- 
formants containing extrachromosomal let-60(Phe-89 
dn), although a dominant Vul phenotype is associated 
with these transformants. This exception is probably the 
result of residual ras activity associated with the mutant 
protein, because the extrachromosomal Iet-60(Phe-89 
dn) DNA can rescue the lethality of let-60(Phe-89 dn)/ 
let-60(Phe-89 dn) homozygotes. Partial vulval differen- 
tiation is also observed in let-60(Phe-89 dn) homozy- 
gotes carrying high copy numbers of the extrachromo- 
somal let-60(Phe-89) gene. The residual activity of let- 
60(Phe-89) could be different qualitatively from the 
residual activity of let-60(Asn-16) or let-60(Asn-119), be- 
cause it does not cause a Muv phenotype, even when 
injected at high concentrations. 
Surprisingly, when injected at 1 ~g/ml, two let-60(dn) 
mutant genes also generated a dominant gain-of-func- 
tion Muv phenotype in addition to the Vul phenotype 
(Table 2). Among a population of animals derived from 
the same transgenic l ne, some are multivulva, while 
others are vulvaless. The Muv phenotype of these trans- 
genic animals might be caused by the r sidual activity of 
let-60(Asn-ll9 dn) and let-60(Asn-16 d_n) proteins ex- 
pressed from the extrachromosomal genes. Whether a 
transgenic animal displays the Vul or Muv phenotype 
might depend on relative level of the dominant-negative 
and residual ctivities. This hypothesis is supported by 
the fact that the let-60(Asn-lI9 dn) allele is recessive 
viable and allows partial vulval differentiation (see be- 
low and Table 3). 
Arg-10 and Asn-119 have distinct properties 
Because the transgene studies indicate two classes of 
dominant-negative mutat ions--those that cause a Muv 
phenotype (Asn-16 and Asn-119J and those that do not 
cause a Muv phenotype (Arg-lO and Phe-89)--we se- 
lected one of each class for further study. Vulval differ- 
entiation in strains containing the Arg-lO and Asn-119 
mutations was analyzed further with Nomarski  optics to 
observe the extent of vulval differentiation. As men- 
tioned earlier, let-60(Arg-lO) homozygotes are inviable 
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Table 3. Dosage ffect of two let-60(dn) alleles on vulval differentiation 
Vulval differentiation 
Genotype a % average (n) b no. < 100% c no. = 100% ~ no. > 100% r
(Arg-lO, Stop-123)/ 
(Arg-lO, Stop-123}/+ a 100 (13) 0 13 0 
+ / + / + 100 (20) 0 20 0 
(Arg-lO)/+ / + 100 {20) 0 20 0 
(Arg-lO)/+ 41 (22) 20 2 0 
(Arg-10)/{Arg-I 0)/+ 4 i l 7) 17 0 .0 
(Arg-10)/{Arg-1 O) lethal 
(Asn-ll9)/+/+ 33 (18) 15 3 0 
{Asn-119)/+ 2 (2Y) 21 0 0 
(Ash-119)~(Ash-119}/+ 79 {28) 10 15 3 e 
(Ash-119)~{Ash-119) 29 (28) 25 3 0 
{Asn- I 19)/(Stop-123) lethal 
"Only the let-60 genotype is indicated. (The complete genotype of each strain is described in Materials and methods.) A duplication 
covering part of chromosome IV (nDp5; Beitel et al. 1990) was used for the additional wild-type copy of let-60. 
bpercentage of vulval precursor cells generating vulval ce ls relative to wild type (100% }, examined under Nomarski optics (defined by 
Han et al. 1990; see Materials and methods). The numbers of animals examined are indicated (n). Two strains listed show an early 
larval ethal phenotype; their vulval cell differentiation cannot be examined. Animals of genotype l t-60(Arg-lO Stop-123}/+ or Df/+ 
have been shown previously to have wild-type vulval development tHan et al. 1990; Beitel et al. 1990). In strains heterozygous for 
let-60(Asn-ll9 dn} and let-60{+), both mutant and wild-type genes contribute to the total activity, although let-60(+) activity is 
greatly reduced by the strong dominant negative ffect of let-60(Asn-119 dn). It is also possible that stability of the mutant proteins 
is different from that of the wild-type protein such that the quantity of the mutant proteins are also different from wild type. 
CNumber of examined animals having <100% vulval differentiation, 100% vulval differentiation, or >100% vulval differentiation, 
respectively. Animals having 100% vulval differentiation do not necessarily have wild-type vulva. 
aStop-123 is a putative null mutation (see text). 
eThree of these 28 let-60{Asn-119)/let-60{Asn-119)/+ animals showed >100% vulval cell differentiation (more than three vulval 
precursor cells generate vulval cells). In these animals, in addition to P5.p, P6.p, and P7.p, P4.p tone animal) or half of the Pn.p progeny 
(P4.pa, two animals differentiated into vulval cells. 
while let-60(Asn-ll9) homozygotes are viable. A chro- 
mosomal duplication (nDpS; Beitel et al. 1990) was used 
to alter the ratio between mutant  and wild-type gene 
dose (Table3). We found that changes in the endogenous 
gene ratio between let-60( + ) and let-60(Arg-10 dn) genes 
cause drastic changes in the extent of vulval differenti- 
ation. In particular, an additional wild-type gene in dn/ 
+/+ animals suppresses the dn toxic effect of let. 
60(Arg-lO dn) completely in dn/+ animals (from 41% 
vulval differentiation to 100%). An additional mutant  
gene reduces the average differentiation to 4% in dn/ 
dn/+ animals (Table 3). Therefore, let-60(Arg-lO dn) 
contains no or little activity by itself but interferes with 
the function of the wild-type gene product. 
The Asn-l l9 dn mutation has more complex effects 
on let-60 ras activity (Table 3). First, let-60(Asn-119 dn) 
exerts a stronger dominant-negative effect than let- 
60(Arg-lO dn): Average vulval differentiation for Asn- 
119/+ and Ash-119/+ / + animals is 2% and 33%, re- 
spectively. Second, let-60(Asn-ll9 dn) has residual ac- 
tivity: let-60(Asn-ll9 dn) homozygous animals are 
recessive viable and have an average of 29% vulval dif- 
ferentiation. Third, the lethal phenotype of let-60(Asn- 
119 dn) in trans to the presumptive null mutation [let- 
60(Arg-lO Stop-123); see above] suggests that the resid- 
ual activity is dose dependent. Two copies of let-60(Asn- 
119 dn) are sufficient for viability, but one copy is not. 
Also, one additional copy of let-60(Asn-119 dn) increases 
vulval differentiation: let-60(Asn-119 dn)flet-60(Asn- 
119 dn) homozygous animals have more vulval differen- 
tiation (29%) than do let-60(Asn-ll9 dn)/+ heterozy- 
gotes {2% ), and dn/dn/+ animals have more vulval dif- 
ferentiation (79%) than do dn/+/+ animals (33%). 
Finally, some multivulva animals (i.e., >100% vulval 
differentiation) were observed among the iet-60(Asn- 
119)/let-60(Asn-119)/+ animals. We found that vulval 
differentiation in these animals is partially signal inde- 
pendent. The gonads of nine animals of this genotype 
were ablated at the L1 stage with a laser microbeam to 
eliminate the source of inductive signal. Three of the 
animals had a total of five and one-half VPCs (for defi- 
nition, see Materials and methods) differentiating into 
vulval tissue, suggesting that let-60 activity in the strain 
is partially constitutive. Therefore, the let-60(Asn-ll9 
dn) gene product has a very strong dominant-negative 
effect on wild-type activity but has some constitutive 
activity by itself to trigger vulval differentiation. 
The dominant-lethal effect of high-dose transgenic 
let-60(Arg-10 dn)is suppressed by the presence 
of the genomic let-60(Glu-13 gf) gene 
The dominant-negative effects of dn alleles are sup- 
pressed completely by gf alleles in let-60(dn)/let-60(gf) 
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animals (Beitel et al. 1990; Han et al. 1990), indicating 
that dn protein cannot compete with gf protein when 
there is one copy of the dn and one copy of the gf mutant 
genes. Because we can drastically alter the relative dose, 
transgenic animals carrying exogenous let-60(Arg-10 dn) 
allow a more stringent est of the hypothesis that dn 
protein cannot interfere with activated ras. 
The DNA array carrying high copy numbers of let- 
60(Arg-lO cln) genes was generated in a let-60(gf) back- 
ground, and the segregants of hermaphrodites of geno- 
type let-60(gf)/+ ; Array were examined for the produc- 
tion (and proportion) of lethal and nonlethal transgenic 
progeny. Table 4 lists the genotypes and phenotypes of 
transgenic animals segregating from a single let-60(Glu- 
13 gf)/ + heterozygote carrying a let-60(Arg-lO cln) extra- 
chromosomal rray injected at 10 ~g/ml (see Table 2). As 
described above, the injected let-60(Arg-lO dn) genes 
cause a dominant-lethal phenotype in a wild-type back- 
ground: None of the 22 transgenic progeny from a gf/+ 
heterozygote has a +/+ genotype (one-fourth is ex- 
pected without the dn effect). However, this lethal phe- 
notype can be weakly suppressed by one copy of let- 
60(Glu-13 gf) in gf/+ heterozygotes and strongly sup- 
pressed by two copies let-60(Glu-13 gf) in gf/gf 
homozygotes. Among the transgenic progeny of gf/+ an- 
Table 4. let-60(Glu-13gf) suppresses the dominant-negative 
effect of extrachromosomal let-60(Arg-10 dn) 
F1 progeny a 
no. of FI 
genotype animals phenotype b 
Average F2 progeny 
nontransgenic transgenic 
gf/gf 15 Muv or WT 92 23 
gf/+ 7 Muv or WT 34 4 
+/+ 0 
aTransgenic progeny of a single let-60(Glu-13 gf)/dpy-20 animal 
carrying extrachromosomal copies of the let-60(Arg-10 dn) gene 
were picked at the L4 larval stage and their genotypes were 
determined by examining their F2 progeny, let-60(Arg-lO dn) 
DNA was injected at 10 ~g/ml along with marker DNA. The 
non-Mendelian segregation pattern of the genotype indicates a
lethal effect caused by extrachromosomal let-60(Arg-10 dn) and 
a suppression effect by let-60(Glu-13 gf). 
BVulval phenotype under dissecting microscope. (Muv) Multi- 
vulva; (WT) wild type. Nine of 15 F 1 gf/gf transgenic animals 
were Muv; two of seven F~ gf/+ transgenic animals were Muv. 
There were no Vul phenotypes observed among all transgenic 
animals. 
CAverage number of F 2 progeny of individual F1 transgenic ani- 
mals. The transgenic animals show the marker phenotype 
(Roller). The relatively large numbers of progeny associated 
with gf/gf animals indicate the stronger suppression of the le- 
thality by a high-copy number of let-60(Arg-lO dn) genes. The 
number of nontransgenic F 2progeny reflects the fertility of F1 
animals. The genotypes of F 2 transgenic progeny of F~ gf/+ 
transgenic animals were not determined (they are expected to 
be a mixture of gf/gf and gf/+ in a ratio similar to that of F 1 
progeny). No vulvaless animals were detected among any of the 
F2 progeny; 166 of 232 progeny of gf/gf F 1 transgenic animals 
were Muv. 
imals carrying extrachromosomal let-60(Arg-lO dn) 
genes, we observed twice as many gf/gf homozygotes {15) 
as gf/+ heterozygotes (7) (Table 4), whereas normally we 
would only expect a ratio of I gf/gf : 2 gf/+ : 1 + / +. The 
Vul phenotype caused by let-60(Arg-lO dn) is also sup- 
pressed completely. Suppression of the dn mutant phe- 
notype by gf mutations has been reported previously in 
yeast cells with either yeast or mammal ian  ras (dn) 
genes (Sigal et al. 1986; Feig and Cooper 1988; Powers et 
al. 1989). The constitutive activity of activated ras (gf) 
mutant proteins is most l ikely the result of a decrease in 
GTPase activity (Barbacid 1987). Therefore, failure of let- 
60(dn) protein to compete with Iet-60 (gf) protein sug- 
gests that the dominant-negative effect of the dn mutant 
proteins on wild-type activity is probably the result of 
disruption of the activation of wild-type ras, rather than 
disruption of its interaction with an effector protein. 
Discussion 
We have demonstrated that nine dn mutations in C. el- 
egans let-60 ras gene [let-60(dn)] cause changes in five 
conserved amino acids that are required for guanine nu- 
cleotide binding in mammal ian  ras proteins. Two of 
these positions are new. Because gf (or "activated") and 
some of the dn mutations of let-60 ras correspond to 
positions that result in gf and dn mutations in mamma-  
lian and yeast ras, it is l ikely that let-60 ras has many of 
the biochemical functions of these other ras proteins 
(e.g., GTP/GDP binding and GTP hydrolysis). Disruption 
of these functions leads to specific developmental de- 
fects in C. elegans. We have also demonstrated that 
these let-60(dn) mutant genes can cause various domi- 
nant mutant phenotypes in transgenic animals. These 
phenotypes uggest hat different properties are associ- 
ated with some of these dn mutations even though each 
mutation interferes with let-60( + ) function in vulval de- 
velopment. Our further dose analysis shows that the 
dominant-negative effect of a mutant gene is separable 
from its ability to be activated, because let-60(Asn-119) 
has the strongest toxic effect on let-60( + ) but, nonethe- 
less, has partial constitutive activity to induce vulval 
differentiation as well as support larval growth. 
Disruption of the essential roles of let-60 ras 
by dn mutations 
Because the putative let-60 null  mutat ion causes ani- 
mals to arrest during the early part of the first larval 
stage, let-60 is required for postembryonic growth and 
development. Similar larval lethality is seen for most 
let-60(dn) homozygotes, suggesting that they are im- 
paired severely in the essential function of this gene. 
However, in let-60(dn)/+ heterozygotes, let-60 function 
during vulval development, but not early larval growth, 
is disrupted: Viable dn/+ animals often have no vulval 
differentiation (Beitel et al. 1990; Han et al. 1990}. There- 
fore, it is possible that the dominant-negative effect is 
tissue specific. The results described here suggest hat 
such an explanation is unl ikely because dominant le- 
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thality can also be produced in wild-type animals by the 
presence of a high copy number of let-60(dn) genes in 
transgenic animals. At least for let-60(Arg-lO dn), this 
lethality is l ikely caused by a strong dominant-negative 
effect that leads to a decrease in let-60(+) activity. 
Therefore, the selective dn effects (disrupting vulval de- 
velopment but not growth) in let-60(dn)/+ animals are 
the result of differences of sensitivity to the decrease in 
let-60 ras activity between these two aspects of develop- 
ment. A similar observation has been made for the gain- 
of-activity mutant phenotype caused by extra copies of 
let-60( + ) genes in transgenic animals (Han and Sternberg 
1990}. Early larval growth thus appears to be less sensi- 
tive to the changes in let-60 activity than is vulval de- 
velopment. 
Mechanism of the dominant-negat ive effect 
of let-60(dn) mutat ions  
The amino acid changes caused by let-60(dn) mutations 
l ikely disrupt the normal interaction between let-60 ras 
protein and GDP or GTP, resulting in loss of protein 
function. Such a defect easily explains the recessive-le- 
thal phenotype. How do these mutant ras proteins, with 
presumably a decreased ability to bind to guanine nucle- 
otides, inactivate the wild-type let-60 ras protein in a 
let-60(dn)/+ heterozygote? Two common models can be 
used to explain a dominant-negative mutant effect (Her- 
skowitz 1987): Either the mutant protein exerts a toxic 
effect in a heteromult imer o the mutant protein com- 
petes with the wild-type protein for another factor. Ac- 
cording to the first model, let-60 ras protein would form 
mult imers through direct or indirect interactions. For 
example, mult iple ras protein molecules may form a 
functional protein complex by interacting with another 
factor. In this model the dominant oxic effect of a dn 
mutant protein is exerted by inactivating a complex con- 
taining both the wild-type and dn ras proteins. If such a 
complex contained more than two Iet-60 molecules, this 
model would be consistent with all of our molecular 
genetic data on let-60(dn), including the Vul phenotype 
of let-60(Asn-119 dn)/+ / + animals (Table 3). However, 
there is no compelling evidence that ras proteins form 
mult imeric omplexes. 
The second model proposes a competition between the 
wild-type and mutant protein for another positive factor 
(Fig. 3). This competit ion results in reduction of the let- 
60( + ) activity in let-60(dn)/+ heterozygous animals. To 
explain the severe Vul phenotype generated by let-60(dn) 
mutations in dn /+ heterozygotes [especially in the case 
of 1et-60(Asn-119), in which vulval differentiation in 
Asn-119/+/+ animals is only 33%], two assumptions 
need to be made. First, the cellular concentration of this 
positive factor must be l imit ing and let-60 ras must be in 
excess in cells responding to the inductive signal (for 
further discussion, see below), so that Iet-60(dn) protein 
could titrate the factor. Second, let-60(dn) proteins must 
form a more stable complex with the factor than the 
wild-type let-60 ras protein. This positive factor could 
either be an upstream activator or a downstream target 
/ 
activato~ [ I 
(eg GNEF) I I _ ' '  
i nact ivG:P~~.~ ~ :r 
negative factor 
(e.g, GAP) 
FUNCTIONS 
Figure 3. A model for the dominant-negative effect of let- 
60(dn) mutant proteins. The mutant protein competes with the 
wild-type protein for an interacting factor, likely an activator. 
The amount of this activator is proposed to be limiting relative 
to the amount of let-60 ras protein, and this activator forms 
more stable complexes with let-60(dn) protein than with let- 
60( + ) protein. Thus, the activator can be titrated by let-60(dn) 
protein molecules that are inactive as a result of the loss of their 
ability to bind guanine nucleotides. The Vul phenotype in let- 
60(dn)/let-60( + } heterozygotes is caused by such a reduction in 
let-60( + ) activity. Because ras is activated by changing from a 
GDP-bound state to a GTP-bound state, this activator could be 
a GNEF (for review, see Bourne et al. 1991). The studies with S. 
cerevisJae RAS and CDC25 proteins {function as a GNEF) pro- 
vide evidence for such a proposal {Powers t al. 1989; Crdchet et 
al. 1990; Jones et al. 1991). Although we propose that the let-60 
ras is in excess relative to the upstream activator, its amount 
may be normally limiting relative to a negative regulator. An 
increased ose of let-60( + ) in transgenic animals causes hyper- 
activity and a Muv phenotype, ras-GTP is deactivated by GTP 
hydrolysis and requires the function of GAP {McCormick 1989; 
Bourne et al. 1991). Such a GAP protein may exist in C. elegans 
to normally limit the activity of let-60 ras. An increase in the 
dose of the wild-type ras gene might overwhelm the negative 
activity of GAP, causing the gf phenotypes (Han and Sternberg 
1990). In wild type, the balance between ras activation and de- 
activation may be controlled by an upstream inductive signal 
through the let-23 receptor tyrosine kinase. The activated let-23 
kinase may either stimulate the function of a GNEF or down- 
regulate the activity of a GAP protein. Either effect would lead 
to activation of let-60 ras. let-60(dn) mutations decrease the 
rate of ras activation constitutively and produce a If phenotype 
regardless of the presence of the upstream signal. 
protein. Because the effect of a dominant-negative mu- 
tant can be suppressed by the presence of constitutively 
active ras protein [let-60(Glu-13 gf)], the let-60(dn) and 
let-60( + ) proteins likely compete for an activator rather 
than a target protein, ras protein is activated through a 
change from the GDP-bound state to the GTP-bound 
state and is deactivated by GTP hydrolysis (Fig. 2; 
Bourne et al. 1991). Therefore, this activator could be a 
guanine nucleotide xchange factor (GNEF; Downward 
et al. 1990; Jones et al. 1991; Kaibuchi et al. 1991). We 
speculate that binding of ras(dn) mutant protein {pre- 
sumably the guanine nucleotide-free protein} to GNEF 
prevents the release of the GNEF and depletes the pool 
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available to interact with, and hence activate, wild-type 
ras protein. 
A competition model has been used previously to ex- 
plain the dominant-negative effect of ras mutations in 
mammalian cells and yeast (e.g., Asn-16, Ala-17, Asn- 
119 of mammalian ras p21 protein and Pro-22 and Ala-25 
of yeast RAS2 protein) (Sigal et al. 1986; Feig and Cooper 
1988; Powers et al. 19891. Particularly, the work done by 
Powers et al. (1989) suggested that CDC25 of Saccharo- 
myces cerevisiae, a yeast GNEF (Cr6chet et al. 1990; 
Jones et al. 1991), is the limiting factor and is titrated by 
binding to ras(+) or ras(dn) proteins. Increased expres- 
sion of the CDC25 gene in yeast can suppress the toxic 
effect caused by a dominant-negative mutation in either 
the yeast RAS2 gene (Ala-22) or the mammalian H-ras 
gene (Ala-15) in the presence of wild-type yeast ras pro- 
tein. Furthermore, because increased dosage of the wild- 
type RAS2 gene neither causes a dominant phenotype 
nor obviously suppresses the dominant-negative effect of 
one dn mutation in yeast, there is no evidence that ras is 
a limiting factor in yeast. 
Although the competition model is consistent with 
our molecular and genetic data on let-60(dn) mutants, so 
far there is no direct evidence for it in either C. elegans 
or mammalian cells. Also, a downstream effector protein 
is not excluded from being the limiting factor that is 
titrated out by some, if not all, of the dominant-negative 
let-60 ras mutant proteins: Suppression of let-60(dn) by 
let-60(GIu-13 gf) may be the result of an even higher 
affinity of let-60(GIu-13 gf) for the effector. In yeast, sup- 
pression of the dn phenotype by increasing the level of 
CDC25 might simply be the result of increase in the 
amount of ras-GTP, which can compete with ras(dn) for 
the effector. 
Negative regulation of let-60 ras 
Our molecular genetic analyses of the let-60 gene sug- 
gest that its product is a limiting factor in signal trans- 
duction. The extent of vulval differentiation is sensitive 
to the number of copies of wild-type or mutant let-60 
genes (Table 3; Beitel et al. 1990; Hart and Sternberg 
19901. In mammalian cells, an increased ose of wild- 
type ras genes causes malignant ransformation (Chang 
et al. 1982; Pulciani et al. 1985; McKay et al. 1986; 
Quaife et al. 19871. The dose effect of the let-60 ras pro- 
tein may be the result of its interaction with a negative 
regulator. For example, ras activity is known to be neg- 
atively regulated by GAP (GTPase-activating protein), 
which catalyzes the GTP hydrolysis of the ras-GTP 
complex (for review, see McCormick 1989; Bourne et al. 
1991). The cellular ras concentration might be limited 
relative to the GAP activity. An increase in dose of the 
wild-type ras gene might overwhelm this negative activ- 
ity of GAP or decrease the rate of GAP-stimulated GTP 
hydrolysis and thus cause a gf mutant phenotype. This 
hypothesis i consistent with the observation that over- 
expression of GAP can suppress c-ras-mediated transfor- 
mation in mammalian cells (Zhang et al. 1990). 
Mechanism of let-60(Asn-119 dn) functions 
The let-60(Asn-119 tin) gene product has the strongest 
dominant-negative effect on let-60( + ) activity but con- 
tains some constitutive activity itself to trigger vulval 
differentiation and to support larval growth (Table 3). 
The residual activity of let-60(Asn-119 dn) protein in the 
vulval signaling pathway is consistent with the proper- 
ties of mammalian ras proteins with changes in residue 
119. For example, ras proteins with residue 119 changed 
from Asp to Ala or His can cause malignant transforma- 
tion in mammalian cells, although these mutant pro- 
teins cause a drastic decrease in affinity for GDP/GTP 
(Der et al. 1986; Sigal et al. 1986). The constitutive na- 
ture of the residual activity associated with changes in 
residue 119 may be due to a decrease in affinity of ras for 
guanine nucleotides that leads to an increase in the ex- 
change rate from ras-GDP to ras-GTP (i.e., causes 
GNEF-independent ras activity; Sigal et al. 1986). There- 
fore, the complicated phenotypes of let-60(Asn-ll  9 dn) 
may be the result of two separable and abnormal bio- 
chemical functions of the protein: On one hand, let- 
60(Asn-119) protein (possibly free of guanine nucle- 
otidesl might form a very stable complex with an acti- 
vator (e.g., GNEF), preventing it from interacting with 
the let-60( + ) protein (see Fig. 31; on the other hand, let- 
60(Asn-ll9) has its own low activity that does not re- 
quire the activation by GNEF and is less sensitive to the 
deactivation by GAP. 
Regulation of let-60 by the inductive signal 
During vulval induction, how is let-60 ras activity reg- 
ulated by the upstream inductive signal and the receptor 
tyrosine kinase encoded by the let-23 gene (Aroian et al. 
1990)? The upstream signal may either activate a GNEF 
that promotes the exchange of ras from GDP- to GTP- 
bound form or down-regulate he activity of GAP, which 
promotes GTP hydrolysis by ras. In the absence of up- 
stream kinase activity, the activation step would be lim- 
iting, but a high dose of wild-type ras might reverse the 
situation. In the presence of the signal, the deactivation 
step would be limiting, but dominant-negative ras mu- 
tations might reverse the situation. This model predicts 
that overexpression f GNEF in wild-type C. elegans will 
cause a multivulva phenotype. 
It is also possible that the in vivo regulation of ras 
activity in these let-60(dn) heterozygotes is more com- 
plicated, perhaps involving the combination of a number 
of positive and negative-regulatory factors or a protein 
complex that exists in a number of distinct states (see 
legend to Fig. 3). Understanding how these dominant- 
negative mutations act should provide insights into the 
mechanism by which ras proteins exert their signal- 
transducing functions. 
Utility of dominant-negative mutations 
Dominant-negative mutations can be a useful tool for 
study in vivo of functions of cloned genes (Herskowitz 
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1987). For example, dn mutations of the Xenopus fibro- 
blast growth factor (FGF) receptor have suggested a role 
of this protein in the patterning of the early Xenopus 
embryo (Amaya et al. 1991). We have shown that partic- 
ular ras dn mutat ions  (e.g., Arg-1 O) disrupt the funct ion 
of ras during vulval development in transgenic animals. 
Such s imple dn mutat ions  might  be useful  to elucidate 
the funct ion of ras in the development of other organ- 
isms. 
Materials and methods 
General methods 
Methods for culturing, handling, and genetic manipulation of C. 
elegans were as described by Brenner (1974). All genetic exper- 
iments were performed at 20~ Methods for analysis of vulval 
defects under dissecting microscope and under Nomarski optics 
were as described previously (Han and Sternberg 1990; Sulston 
and Horvitz 1977). The genetic nomenclature used was as de- 
scribed (Horvitz et al. 1979). let-60(dn) strains were described by 
Han et al. (1990) and Beitel et al. (1990). Other strains were 
constructed according to standard methods. 
Microinjection transformation 
Each construct was injected into dpy-20(e1282) {Hosono et al. 
1982) hermaphrodites together with pMH86 {containing the 
dpy-20 gene) (15-25 txg/ml). To keep total DNA concentration 
approximately the same, Bluescript (SK+) plasmid was coin- 
jetted at 50 }xg/ml. Because of the large number of F 1 transfor- 
mants {non-Dpy animals) produced, the number of F1 transgenic 
animals listed in Table 2 is approximate. For some experiments 
described in Table 2, about four to eight F~ transformants were 
pooled on a single plate for screening for stable lines. Each plate 
containing F2 transformants was scored as one stable line; thus, 
the number of stable lines listed in Table 2 is a minimum. 
For the experiments described in Table 4, a dominant rol-6 
mutant gene (pRF4; Mello et al. 1991; 50 ~g/ml) and dpy-20 
gene (pMH86; 10 }xg/ml} were coinjected into let-60(n1046 gf)/ 
dpy-20(e1282) hermaphrodites along with 10 ~g/ml of let- 
60(sylO1 dn) DNA (pMH136). pMH86 is a Bluescript (SK+)- 
derived plasmid that has a 6-kb XbaI DNA insert containing the 
entire dpy-20 gene {subcloned from a dpy-20-containing 
cosmid; D. Clark and D. Baillie, pers. comm.). Because the Dpy 
phenotype of dpy-20 homozygotes, which normally suppresses 
the roller (Rol) phenotype, is rescued in the transgenic animals 
by the extrachromosomal dpy-20 gene, the dominant Rol phe- 
notype is associated with all transgenic animals. 
Determining the nucleotide changes in let-60 mutants 
DNA fragments containing let-60-coding regions were obtained 
by polymerase chain reaction (PCR) amplification from ho- 
mozygous mutant animals (which are dead larvae, in most 
cases). The method for PCR amplification of DNA from dead 
larvae was as described by Beitel et al. (1990). Sequences of the 
mutant DNA were determined by one or both of the two meth- 
ods: In most cases, PCR-amplified DNA fragments were di- 
rectly sequenced after gel purification (Kretz et al. 1989); in 
some cases (exon 1 of sy94 and sylO1; exons 2 and 3 of sy92, 
sy93, sy95, and sylO0), PCR fragments were subcloned {see be- 
low) and then sequenced. In later cases, the DNA lesion of each 
mutation was confirmed by sequencing multiple clones, or in 
the case of sy94 and sylO1, by also sequencing el-purified am- 
plified fragments. All four exons have sequenced for all 11 alle- 
les listed in Table 1. Four determined DNA lesions (represent- 
ing seven genetically isolated dn alleles) were also tested func- 
tionally for their dn effects by microinjection experiments 
(Table 2). There had been ambiguity of the dn allele (either 
syl O1 or sy94) used to generate sy127 (Han and Sternberg 1990). 
Our sequence analysis howed it to be sy101, and we will thus 
refer it as sylOl sy127 (or Arg-lO Stop-123). 
In vitro construction f let-60(dn) genes 
New plasmids were constructed to facilitate the construction of
mutant let-60 genes, pMH105 was first generated by deleting 
part of the linker region {between EcoRI and ApaI) of vector 
Bluescript {SK+ ). This deletion was achieved by digesting the 
Bluescript (SK + ) with EcoRI and ApaI and then self-ligating the 
large fragment after end-filling with T4 polymerase. A 6.8-kb 
BamHI-XhoII genomic fragment containing the entire let-60 
gene (Han et al. 1990) was inserted into the BamHI site of 
pMH105. The resulting plasmid, called pMH106, was u ed sub- 
sequently for subcloning let-60(dn) fragments. For alleles lo- 
cated in exon 1, the HindIII-ApaI fragment of pMH106 was 
replaced by mutant DNA fragments; for alleles located in exon 
2 or 3, the ApaI-EcoRV fragment of pMH106 was replaced by 
mutant DNA fragments. 
Estimation of copy numbers of extrachromosomal 
let-60 genes 
To estimate extrachromosomal copy number, a let-60 DNA 
fragment was amplified by PCR from L4-stage stable transgenic 
animals as well as nontransgenic dpy-20 animals. To keep PCR 
amplification i  a linear range, only 15 rounds of amplification 
were performed {Robinson and Simon 1991). The PCR products 
were loaded on an agarose gel, and the amount of amplified 
DNA was detected by Southern analysis. As a control, primers 
were also added to each reaction to amplify a DNA fragment 
located in the let-23 gene (chromosome II) {Aroian et al. 1990). 
For each transgenir line, three to four animals were first lysed 
with proteinase K in 20 Ixl. The lysate (2x 2 txl and 2x 5 ixl) was 
then added to one of the four tubes containing the PCR mix. 
The relative intensity of the two DNA bands on an autoradio- 
graph was measured by a densitometer (LKB). The number of 
extrachromosomal let-60 genes listed in Table 2 is the average 
of the four measurements for each transgenic line. 
Strain construction 
To construct strains containing nDp5 and let-60(sy101 dn), dpy- 
20(e1362) unc-22(e66)/dpy-20(e1362) unc-22(e66); nDp5; him- 
5(e1490), males (Beitel et al. 1990) were crossed with let- 
60(sy101 dn) dpy-20(e1282)/let-60(n1046 gf) unc-22(sT) her- 
maphrodites. Non-Dpy non-Unc F1 cross progeny were picked 
and placed individually on new plates. F1 progeny of the geno- 
type let-60(sylO1 dn) dpy-20(e1282)/dpy-20(e1362) unc- 
22(e66); nDp5 were selected by analyzing F~ segregants. A strain 
of genotype let-60(Arg-lO dn) dpy-20(e1282)/let-60(sy101 dn) 
dpy-20(e1282); nDp5 was obtained from screening the F 2 prog- 
eny. The complete genotype for let-60(sylO1 dn)/+ animals is 
let-60(syl01 dn) dpy-20(e1282)/let-65(s254) unc-22(sT) unc- 
31(e159) (Han et al. 1990). To construct strains containing let- 
60(sy93 dn) and nDp5, a strain of genotype unc-24(e138) 
mec-3(e1338) dpy-20(e1282)/unc-24(e138) mec-3(e1338) dpy- 
20(e1282); nDp5; him-5(e1490) was constructed first. Males of 
this strain were then crossed with unc-24(e138) let-60(sy93dn)/ 
unc-24(e138) let-60(sy93 cln) hermaphrodites (Hall et al. 1990). 
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The F1 non-Unc cross progeny were picked and have the geno- 
type unc-24 1et-60(sy93 dn)/unc-24 mec-3 dpy-20(e1282); 
nDp5; him-5(e1490)/ +. A strain of genotype 1et-60(Asy93 dn)/ 
unc-24 let-60(sy93 dn); nDp5 was obtained from F2 or F a prog- 
eny. 
Examining vulval differentiation with Nomarski optics 
For let-60(dn)/+ / + and + / + / + animals, self progeny (late L3 
or early L4 larvae) of let-60(dn)/+ / + hermaphrodites were first 
examined for vulval induction, and their genotypes were deter- 
mined by progeny testing. Except for + / + / + animals, vulval 
differentiation was determined by examining the progeny from 
mothers of the same genotype. 
The percentage of vulval differentiation is determined asthe 
percentage of vulval precursor cells (P3.p--P8.p) differentiating 
into vulval cell type relative to wild type (as defined by Han et 
al. 1990). In a completely vulvaless animal, each of the six 
precursor cells divides once, and their progeny appears to fuse 
with the syncytial hypodermis. The vulval differentiation i
such an animal is said to be 0%. In a wild-type hermaphrodite 
(100% vulval differentiation], three of the six precursor cells 
divide further than the first round of division, producing the 
progeny characteristic of vulval cell types (Sulston and Horvitz 
1977; Sternberg and Horvitz 1986). Animals with fewer than 
three cells differentiating to vulval cell types have < 100% vul- 
val differentiation (vulvaless); animals with more than three 
precursor cells differentiating to vulval cell types have >100% 
vulval differentiation (multivulva). Sometimes only one of the 
two daughters of a precursor cell divided further to generate 
vulval tissue; the vulval differentiation i  this case is "one-half 
cell". Laser ablation experiments were performed as described 
(Sulston and White 1980). 
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